Articles by Daniel Marsh
Clearwater Analytics Ends Trading at $24.56, Closing $8.4B Buyout
Clearwater Analytics shares traded their last session at $24.56, just above the $24.55 deal price, completing an $8.4B all-cash buyout by Permira and Warburg Pincus.
Unicycive Therapeutics Plunges After FDA Issues Second CRL on Kidney Drug
Unicycive Therapeutics shares plunged nearly 48% in premarket trading Tuesday after the FDA issued a second complete response letter for its kidney disease drug, oxylanthanum carbonate, due to third-party manufacturing issues.
Jack in the Box Surges on Russell Microcap Inclusion and Short Squeeze
Jack in the Box (JACK) shares surged 31% since Friday, driven by Russell Microcap inclusion and a short squeeze, with volume spiking to 4x the average.
Exemplar Luxury Group Exits Chapter 11, Debt Halved to $1.2 Billion
Exemplar Luxury Group exits bankruptcy with 49 luxury stores and $1.2 billion in debt, but vendor trust and wholesale dependence remain key challenges.
Abivax Shares Surge on Improved Safety Data for Ulcerative Colitis Drug
Abivax shares rallied 35.77% in Paris after updated safety data showed malignancy rates for obefazimod fell within expected ulcerative colitis background levels.
BTC Digital Soars 84% Premarket After $7M Raise Exceeds Market Cap
BTC Digital shares jumped 84.5% premarket after the company raised $7 million in a private placement, exceeding its market cap, to fund an AI computing center in Georgia.
Nokia Surge Drives Nearly Half of Helsinki Index's Tuesday Gain
Nokia surged 4.46%, contributing roughly 41% of the OMX Helsinki 25's gain. The stock remains below its June 25 close ahead of Q2 earnings on July 23.




